Related Experiment Video
Updated: Jan 25, 2026

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair
Published on: May 23, 2014
Osteogenic circulating endothelial progenitor cells are linked to electrocardiographic conduction abnormalities in
Yap-Hang Chan1, Michael Cheong Ngai1, Yan Chen1,2
1Cardiology Division, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
Insights
Elevated osteogenic endothelial progenitor cells (EPCs) expressing osteocalcin (OCN+) are linked to cardiac conduction abnormalities in rheumatoid arthritis patients. This finding suggests a new mechanism in cardiovascular degeneration.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Cell Biology
Background:
- Endothelial progenitor cells (EPCs) contribute to cardiovascular degeneration via vasculature calcification.
- The role of osteogenic EPCs in cardiac conduction disorders was previously unknown.
- Rheumatoid arthritis (RA) patients exhibit increased risk for bone metabolism and cardiac conduction issues.
Purpose of the Study:
- To investigate the association between osteocalcin (OCN)-expressing EPCs and cardiac conduction disorders in RA patients.
- To explore a potential link between abnormal bone metabolism and cardiac electrical abnormalities in RA.
Main Methods:
- Flow cytometry analysis of 134 asymptomatic RA patients.
- Quantification of osteogenic OCN-positive (OCN+) CD34+KDR+ EPCs and conventional CD34+CD133+KDR+ EPCs.
- Assessment of electrocardiographic conduction abnormalities as the primary endpoint.
Main Results:
- A significant elevation in OCN+ CD34+KDR+ EPCs was observed in patients with cardiac conduction abnormalities (p=0.039).
- Higher levels of OCN+ CD34+KDR+ EPCs (>75th percentile) were strongly associated with increased prevalence of conduction abnormalities (p=0.003).
- Elevated OCN+ CD34+KDR+ EPCs remained an independent predictor of cardiac conduction abnormalities (OR=4.4, p=0.028), while conventional EPCs showed no significant association (p=0.36).
Conclusions:
- Increased levels of osteogenic OCN+ CD34+KDR+ EPCs are independently associated with electrocardiographic conduction abnormalities in RA patients.
- This study highlights a novel pathophysiological mechanism linking osteogenic EPCs to cardiac conduction disorders.
- Osteogenic EPCs may represent a new therapeutic target for managing cardiovascular complications in RA.
Background:
Osteogenic circulating endothelial progenitor cells (EPC) play a pathogenic role in cardiovascular system degeneration through promulgating vasculature calcification, but its role in conduction disorders as part of the cardiovascular degenerative continuum remained unknown.
Aim:
To investigate the role of osteocalcin (OCN)-expressing circulating EPCs in cardiac conduction disorders in the unique clinical sample of rheumatoid arthritis (RA) susceptible to both abnormal bone metabolism and cardiac conduction disorders.
Methods:
We performed flow cytometry studies in 134 consecutive asymptomatic patients with rheumatoid arthritis to derive osteogenic circulating OCN-positive (OCN+) CD34+KDR+ vs. CD34+CD133+KDR+ conventional EPC. Study endpoint was the prespecified combined endpoint of electrocardiographic conduction abnormalities.
Results:
Total prevalence of cardiac conduction abnormality was 9% (n = 12). All patients except one had normal sinus rhythm. One patient had atrial fibrillation. No patient had advanced atrioventricular (AV) block. Prevalence of first-degree heart block (>200 ms), widened QRS duration (>120 ms) and right bundle branch block were 6.7%, 2.1%, and 2.2% respectively. Circulating osteogenic OCN+ CD34+ KDR+ EPCs were significantly higher among patients with cardiac conduction abnormalities (p = 0.039). Elevated OCN+ CD34+ KDR+ EPCs> 75th percentile was associated with higher prevalence of cardiac conduction abnormalities (58.3% vs. 20.02%, p = 0.003). Adjusted for potential confounders, elevated OCN+ CD34+ KDR+ EPCs> 75th percentile remained independently associated with increased risk of cardiac conduction abnormalities (OR = 4.4 [95%CI 1.2-16.4], p = 0.028). No significant relation was found between conventional EPCs CD34+CD133+KDR+ and conduction abnormalities (p = 0.36).
Conclusions:
Elevated osteogenic OCN+ CD34+ KDR+ EPCs are independently associated with the presence of electrocardiographic conduction abnormalities in patients with rheumatoid arthritis, unveiling a potential novel pathophysiological mechanism.
More Related Videos
11:56In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
Published on: May 15, 2014
07:26Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
Published on: September 14, 2017
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Respiratory System Abnormal Finding I: Inspection and Percussion
Inspection Findings
During an inspection, several findings may suggest the presence of respiratory distress or disease. Pursed-lip breathing, where exhalation is slowed by...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Rheumatic Heart Disease I: Introduction